Japanese Journal of Clinical Pharmacology and Therapeutics
SJR0.126
JP
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | — | — | 0.126 | Q4 | 9.0% | |
| 2024 | — | — | 0.112 | Q4 | 7.9% | |
| 2023 | — | — | 0.119 | Q4 | 16.6% | |
| 2022 | — | — | 0.127 | Q4 | 22.8% | |
| 2021 | — | — | 0.102 | Q4 | 15.9% | |
| 2020 | — | — | 0.105 | Q4 | 1.8% | |
| 2019 | — | — | 0.112 | Q4 | 13.7% | |
| 2018 | — | — | 0.113 | Q4 | 4.2% | |
Impact history
Annual SJR and Impact Factor trend.
SJR
Journal record
eISSN
0388-1601
ISSN
1882-8272
country
coverage
1970-2025